Mylan Bertek Pharmaceuticals Inc.
Records under this name other than patents Mylan Bertek Pharmaceuticals Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 6 of 6 · Back to Mylan Bertek Pharmaceuticals Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,143,794 | Topical formulations for the treatment of nail fungal diseases Term ended Term ended Apr 9, 2019 · USPTO record | Term ended | Term ended Apr 9, 2019 | USPTO record |
| US 6,262,041 | Use of vitamin D analogs to treat conditions related to increased oxidative stress Term ended Term ended Apr 6, 2019 · USPTO record | Term ended | Term ended Apr 6, 2019 | USPTO record |
| US 6,277,364 | Polyurethanes as topical skin protectants Term ended Term ended Oct 9, 2018 · USPTO record | Term ended | Term ended Oct 9, 2018 | USPTO record |
| US 6,075,056 | Antifungal/steroid topical compositions Term ended Term ended Oct 3, 2017 · USPTO record | Term ended | Term ended Oct 3, 2017 | USPTO record |
| US 5,650,171 | Retinoic acid-containing polyether-polyurethane compositions Term ended Term ended no later than Jul 22, 2017 · Low confidence | Term ended | Term ended no later than Jul 22, 2017 | Low confidence |
| US 5,700,483 | Retinoic acid-containing compositions Term ended Term ended no later than Dec 23, 2017 · Low confidence | Term ended | Term ended no later than Dec 23, 2017 | Low confidence |